BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Therap’s Disability Software Allows for Efficient Tracking of Health Data for Improved Outcomes

  Therap’s health tracking features give provider agencies a range tools to efficiently track health data and visualize the data with a variety of detailed reports.

  February 10, 2020

   · 

  2 min read
• Pharm Country

  Diverse Biotech selected to present at upcoming BIO Meeting and announces new Gene Expression Paper Publication

  Diverse Biotech, Inc. www.diversebiotech.com has announced it has been selected to present at the upcoming BIO CEO & Investor Conference in New York on February 11th.

  February 10, 2020

   · 

  1 min read
• Business

  Border Therapy Services Announces New Clinic In Las Cruces, New Mexico

  Border Therapy Services and Alliance Physical Therapy Partners is pleased to announce the opening of their new outpatient rehabilitation clinic located at 3330 Rinconada Blvd.

  February 10, 2020

   · 

  2 min read
• Business

  RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada

  RadioMedix, and OncoBeta today announced the execution of an exclusive distribution agreement for the next generation of W/Re-188 generators in the U.S. and Canada.

  February 10, 2020

   · 

  4 min read
• Genetown

  ReWalk Robotics Announces Closing of $7.0 Million Public Offering

  ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing and funding of its previously announced public offering of 4,053,172 units at a price to the public of $1.25 per unit and 1,546,828 pre-funded units at a price to the public of $1.249 per pre-funded unit.

  February 10, 2020

   · 

  6 min read
• Business

  Halozyme To Host Fourth Quarter And Full Year 2019 Financial Results Webcast And Conference Call

  Halozyme Therapeutics, Inc. will webcast its Quarterly Update Conference Call for the fourth quarter 2019 on Monday, February 24 at 4:30 p.m. ET / 1:30 p.m. PT.

  February 10, 2020

   · 

  1 min read
• Business

  Luminex Corporation Reports Fourth Quarter and Full-Year 2019 Results

  Luminex Corporation announced results for its fourth quarter and full-year ended December 31, 2019.

  February 10, 2020

   · 

  9 min read
• Policy

  Leidos Announces Formation of Scientific Advisory Board to Advance its Pre-Clinical Drug Development

  Leidos, a FORTUNE® 500 science and technology leader, announced the formation of a Scientific Advisory Board for its Explorations in Global Health division within the Leidos Health Group.

  February 10, 2020

   · 

  3 min read
• Genetown

  AVROBIO Presents Positive Initial Data for its Investigational Cystinosis Program and Plato TM Platform, as well as Positive Data Out to 32 Months for its Ongoing Investigational Fabry Program

  Early data trends from first patient dosed in the AVR-RD-04 investigational gene therapy program for cystinosis show improvements across multiple measures

  February 10, 2020

   · 

  16 min read
• Business

  Retrophin to Report Fourth Quarter and Full Year 2019 Financial Results

  Retrophin, Inc. announced it will report fourth quarter and full year 2019 financial results on Monday, February 24, 2020 after the close of the U.S. financial markets.

  February 10, 2020

   · 

  1 min read